Abstract
About 40 % of woman suffer from vulvovaginal atrophy after menopausal transition. It is very important to put question on this problem, because about 70 % of them are not able to start discussion on it.
Regarding treatment, vaginal low doses estriol and estradiol are drugs of first choice with high efficacy and safety.